LUXEMBOURG / ACCESSWIRE / February 3, 2020 / Jean Boulle Medtech Ltd. (the "Company"), founder of Tendyne Holdings, Inc. ("Tendyne") and a Jean Boulle Group (the "Group") company developing medical ...

PARIS, May 23, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne Transcatheter Mitral Valve Replacement ...

ABBOTT PARK, Ill., Jan. 30, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Tendyne™ Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use ...

ABBOTT PARK, Ill., July 26, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has initiated a pivotal clinical study in the U.S. of its Tendyne Transcatheter Mitral Valve Replacement (TMVR) ...

Two-year outcomes following transcatheter mitral valve replacement with the Tendyne prosthesis showed durable control of mitral regurgitation, sustained improvement in quality of life and functional ...

Minneapolis Heart Institute Foundation is the first research center in the USA to report implant of a TMVR Device ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne") a privately held clinical stage ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

For high-risk surgical patients with severe symptomatic mitral regurgitation (MR), insertion of the Tendyne transcatheter mitral valve replacement (TMVR; Abbott) using a cardiac transapical approach ...

Tendyne’s self-expanding valve replacement includes a dual-frame design—an inner bioprosthetic, plus an outer ring that contours to the shape of the patient’s natural mitral valve—and is available in ...

ROSEVILLE, Minn., Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully ...

- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option As the most common heart disease affecting the heart valves, MR ...

The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a ...